LIMD1-AS1

Across TCGA pan-cancer cohorts, LIMD1-AS1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LIMD1-AS1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LIMD1-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LIMD1-AS1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and MESO show a favorable association.

SKCM, MESO, and BRCA are the cancer types where LIMD1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.422	0.267	<.001	105	view →
MESO	OS	Tertile	All	0.867	0.273	.001	50	view →
BRCA	OS	Tertile	IV	0.936	0.425	.002	43	view →
LUSC	DFS	Quartile	III,IV	0.206	1.000	<.001	37	view →
ACC	OS	Median	III,IV	0.705	0.254	.008	28	view →
HNSC	DFS	Tertile	IV	0.718	0.548	.002	26	view →
KIRP	DFS	Tertile	IV	0.765	0.049	.006	22	view →
UVM	OS	Median	II,III,IV	0.827	0.585	.025	21	view →
PAAD	OS	Median	All	0.624	0.418	.014	19	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	18	view →
KIRC	DFS	Median	All	0.702	0.551	.023	13	view →
CESC	OS	Quartile	All	0.863	0.701	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LIMD1-AS1–SKCM (OS)

Open the SKCM breakdown →